MDXG Q4 2017 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M+25.3% YoY

Gross Profit

$79M90.6% margin

Operating Income

$24M27.4% margin

Net Income

$35M39.8% margin

EPS (Diluted)

$0.31

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$20M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$121M

Total Liabilities

$47M

Stockholders' Equity

$74M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$70M	+25.3%
Gross Profit	$79M	$61M	+30.4%
Operating Income	$24M	$9M	+175.2%
Net Income	$35M	$5M	+536.3%